Trimetazidine decreases Ca2+ response to thapsigargin in differentiated and undifferentiated human HL-60 cells.
Astashkin
E I
EI
Sechenov Moscow Medical Academy, ul. Malaya Trubetskaya 8, Moscow, 119881, Russia.
Glezer
M G
MG
Grachev
S V
SV
D015220:Calcium Channels / Q000187:drug effects / Q000378:metabolism; D020013:Calcium Signaling / Q000187:drug effects*; D002454:Cell Differentiation; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D005227:Fatty Acids / Q000378:metabolism; D018922:HL-60 Cells; D006801:Humans; D015759:Ionomycin / Q000494:pharmacology; D008563:Membrane Lipids / Q000378:metabolism; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000494:pharmacology; D019284:Thapsigargin / Q000494:pharmacology*; D014292:Trimetazidine / Q000494:pharmacology*
D015220:Calcium Channels; D005227:Fatty Acids; D008563:Membrane Lipids; D015759:Ionomycin; D009240:N-Formylmethionine Leucyl-Phenylalanine; D019284:Thapsigargin; D014292:Trimetazidine